Skip to main content

SGMA

Menu
LEADERSHIP

Our Leadership

SGMA’s leadership brings together scientists, clinicians, methodologists, and industry experts with a shared commitment to method-driven population standards in healthcare and clinical research.

FOUNDERS & BOARD OF DIRECTORS

Provides strategic, fiduciary, and organizational oversight to guide SGMA’s mission, governance, and long-term sustainability.

Craig Davenport

SECRETARY & BOARD DIRECTOR
SHOW BIO

Kemi Williams

BOARD DIRECTOR
SHOW BIO

Garo Kiledjian

FOUNDER & CEO
SHOW BIO

ADVISORY BOARD

Offers specialized expertise and perspective to inform SGMA’s programs, research priorities, and strategic initiatives.

Dr. Lauren B. Beach, JD, PhD

SHOW BIO

Brenda Crabtree-Ramírez, MD

SHOW BIO

Randy Davis

SHOW BIO

Jacky Goh

SHOW BIO

Lisa Moneymaker

SHOW BIO

Kunal Patel, MD, BAO, Bch, BA, MRCS, DTM&H, PhD

SHOW BIO

David Sall

SHOW BIO

Hank Scott

SHOW BIO

NFN Scout, MA, PhD

SHOW BIO

Laura Waters, MD

SHOW BIO

EMERITUS BOARD

Honors former leaders whose expertise, perspectives, or longstanding support have enriched SGMA’s work. Emeritus members help carry forward SGMA’s institutional memory and may be invited to offer insight or serve as ambassadors, without governance responsibilities.

Lorena Kuri, MSMHC

SHOW BIO

Demetre Daskalakis, MD, MPH

SHOW BIO

Karen Parker, PhD

SHOW BIO

Michael Wohlfeiler, MD, JD

SHOW BIO

Dr. Ben Young, MD, PhD, FIDSA

SHOW BIO

Get Involved

Comment on Standards

Review and comment on SGMA’s population standards during the open public comment period.

Comment Now

Partner with us

Join the organizations building population standards infrastructure across clinical research and healthcare.

Get in touch

Support us

Support SGMA’s work developing open-access population standards for global clinical research.

Donate

Stay Current on Population Standards

Craig Davenport

Craig is a recent retiree of Eli Lilly and Company where he worked for 34 years in research and development. In all roles at Lilly, Craig championed diversity and equity in clinical research, none more so than his final role as Vice President of Investigator Engagement where he brought the company to be a flagship partner of SGMA. His prior leadership roles at Lilly included working in China for four years as Senior Director China Clinical Development and five years in Japan as Managing Executive Officer & Director of Drug Development for Eli Lilly Japan K.K. Other roles included Chief Operations Officer on the Cialis™ Product Team, which set new standards for innovation in clinical research.

At Lilly, he was twice recognized with Lilly Research Laboratories President’s Award, the Excellence in Alliance Practice Award, and was one of twelve employees selected to serve on the first Lilly President’s Council.

Craig is a graduate of Butler University College of Pharmacy where he continues to be involved in the advancement of health care professional care education, serving two terms on the College of Pharmacy Board of Visitors. Craig was voted Butler’s Outstanding Student in 1990 and later received the Joseph Irwin Sweeney Young Alumni Award. He was later selected to be among the Top 50 Alumni Under 50.

While he now works as a consultant to pharma, focusing on late-stage clinical research innovation, his primary focus is on developing organizations that advance representation of sexual orientation and gender identity minorities. Craig has recently been an invited speaker on the topic of diversity and inclusion in clinical research at SCRS, Scope, and Partners.

He is delighted to join SGMA as a Board Member. The mission of SGMA is one of both passion and purpose for Craig. Never has the imperative of inclusiveness in clinical research been more pressing, and never has science and technology been more aligned to reveal the truths we seek in the development of new medicine.

Kemi Williams

Dr. Kemi Williams is a visionary clinical research and health equity leader with 25 years of experience transforming global clinical trials and advancing equitable access to medical innovations. Her career spans strategic partnership development, trial design and execution across diverse therapeutic areas, and the building of clinical site networks in both developed and emerging markets.

Most recently at AstraZeneca, Dr. Williams pioneered patient-centered trial representation strategies and health equity frameworks that expanded global access to clinical research. She shaped and launched the company’s external partnership strategy on inclusive research, leading cross-functional teams across Biopharma, Oncology, and Rare Diseases to create best practices in clinician and health system engagement. Prior to that, her leadership also strengthened research ecosystems through equity-focused discovery, innovative trial models, genomic research collaborations, and capacity building with leading academic institutions.

Dr. Williams holds a BSc in Computer Science, an MBA, and a PhD in Health Sciences. Her work is guided by a bold and unwavering vision: to transform global trial representation and scale equitable health access, not simply to meet regulatory milestones, but to create lasting health system impact and ensure that life changing medical innovations reach every patient who needs them.

Garo Kiledjian

Garo Kiledjian is the Founder & CEO of SGMA. He founded the organization after identifying systemic methodology failures in clinical research — specifically the exclusion of people living with HIV from research and healthcare participation based on outdated eligibility language. After years of raising these concerns through industry channels, he publicly challenged the field at a national conference, generating immediate engagement from CDC, NIH, and more than a dozen pharmaceutical organizations. Under his leadership, SGMA has grown from a founding declaration to a global standards program with published frameworks, peer-reviewed publications in progress, and partnerships across pharma, academia, and regulatory bodies. He holds a Bachelor’s degree from UCLA and studied Leadership and Global Strategy at Woodbury’s Graduate School of Business.

Lauren B. Beach

Lauren B. Beach, JD, PhD, is an Assistant Professor within the Department of Medical Social Sciences and Department of Preventive Medicine in the Feinberg School of Medicine at Northwestern University. They are the director of the ReACH Lab and ADVOCATE Program within Northwestern’s Institute for Sexual and Gender Minority Health and Wellbeing (ISGMH).

Dr. Beach investigates the epidemiology of chronic physical health conditions over the life course among diverse SGM populations and people with HIV. They also study how multilevel health and identity related stigmas affect chronic condition management and health outcomes of minoritized populations.

Along with Sumanas Jordan MD, PhD, they lead the Advancing Opportunities in Clinical and Translational Equity in SGM Health (ADVOCATE SGM Health) Program, which focuses on advocating for good quality care and research-practice-policy improvements in community and public health.

Brenda Crabtree-Ramírez

Dr. Crabtree is an infectious disease physician-scientist, Professor of the HIV Program (Universidad Nacional Autónoma de México, UNAM), and a senior researcher of the HIV clinic of the Infectious Diseases Department at the Instituto Nacional de Ciencias Médicas y Nutrición, Salvador Zubirán, Mexico City. Dr. Crabtree is the PI for the Caribbean, Central and South America network for HIV epidemiology (CCASAnet) of the global International Epidemiology Databases to Evaluate AIDS (IeDEA) consortium, and leader of the research site of Mexico City from the ACTG Network. Her main area of research is HIV treatment clinical trials and observational studies of advanced HIV disease and co-morbidities among people with HIV. 

Randy Davis

HIV Activist/Advocate and U=U Champion
The Accidental HIV Activist

Randy Davis is a Canadian HIV advocate, speaker, and writer who has emerged as one of the leading voices promoting U=U (Undetectable = Untransmittable) and challenging stigma in Canada and globally. Diagnosed with HIV in 2015, Randy transformed a personal journey into a platform for public education, advocacy, and policy engagement.

He is the creator of the I Can Give U campaign, an international initiative that humanizes people living with HIV and champions accurate messaging about U=U. Randy also founded InclusHIV Consulting, where he advises organizations, healthcare providers, and advocates on how to build more inclusive and stigma-free practices.

Randy is a National Ambassador with the Canadian Foundation for AIDS Research (CANFAR), sits on the Canadian Coalition to Reform HIV Criminalization, a board member of the Ontario AIDS Network, and a mentor in the International AIDS Society Mentorship Programme. He advocates for a healthcare landscape where people living with HIV and those on PrEP are fully included, respected, and empowered.

A frequent speaker at national and international conferences, Randy was recently awarded the King Charles III Coronation Medal for his contributions to the HIV movement.

You can find his writing and advocacy work at The Accidental HIV Activist on Substack and across social media.

Jacky Goh

Jacqueline “Jacky” Goh serves as the Chief Development Officer for the National LGBTQ Task Force. In this role, Jacky leads the Task Force’s fund development efforts and is responsible for strengthening the infrastructure needed to support and grow the organization’s budget through foundation, corporate, and individual donors, as well as other vital revenue streams.


As a queer Korean woman, Jacky has long understood the importance of allyship and collective liberation. She recognizes the ways that she has benefitted from others who have fought to defend and protect her existence, and she has dedicated her career to paying it forward. In her previous role as Senior Director of Development for the Center for Employment Opportunities, she raised funds to support formerly incarcerated individuals in their reentry into the workforce. She was the Director of Strategic Growth at Define American, a culture change organization that uses the power of narrative to humanize conversations about immigrants. She has also raised funds to advance economic mobility, housing security, and health equity with her work at Restaurant Opportunities Center United, Esperanza Community Housing Corporation, and the Center for Youth Wellness.


Jacky has extensive experience with Board and donor engagement and strategic planning. She holds a Bachelors in Sociology and a Masters in Clinical Psychology with specializations in LGBT Affirmative Psychology and Applied Community Psychology from Antioch University.


Jacky lives in Los Angeles. She is an avid crossworder and grateful companion to two furry felines, Dummy (who is actually very smart) and Alby (who enjoys saying hello on zoom calls).

Lisa Moneymaker

Lisa Moneymaker is a seasoned leader in the intersection of technology and clinical research, with nearly 25 years of experiences across pharma, biotech, and medical devices. Her roles include leadership of product, engineering, AI research, and customer engagement organizations within both sponsor and product technology companies – supporting the industry’s ever-evolving need for innovative technology to improve clinical development and patient outcomes. Lisa serves as the vice chair of ACRO, and is on the advisory board for the SGMA.

Kunal Patel

Dr. Kunal Patel is an International Health physician and Medical Director at iheed. He is an academic and global health specialist whose work focuses on the themes of global health and the interface between technology, patients, health education and training. Dr. Patel has worked extensively within the international development sector, forming partnerships and developing research, which has been instrumental for primary care system strengthening, improving health outcomes and improved advocacy for the use of public health approaches for clinical research using technology and in advocating for the greater health education globally. He is the Programme Director for the Masters in Public Health at the University of Warwick/iheed and his recent clinical work has focused heavily on supporting the humanitarian response to the conflict in the Middle East and NGO response work. Recent publications have included the world’s leading review on compassion in AI-driven healthcare and narrative reviews on topics such as interprofessional collaboration and learning in diabetes care.

David Sall

David Sall is a Marketing and Engagement specialist focused on the healthcare sector.  He graduated with Honors from The George Washington University with a degree in Communications and a concentration in Business Marketing. 

His career started in national broadcasting sales representing hundreds of the nations top radio properties.  As media hit the technology evolution David continued his career by building and managing the New York office for Highwire, a pioneer in digital streaming technology.  With the opportunity to bring his digital knowledge to the traditional media space David joined CBS Broadcasting’s management team handling the flagship radio news properties and digital assets of the Tiffany network.

Currently, David has started his own venture, Patient Enrollment Advisors, focused in Healthcare.  This venture was born out of a clear need for an industry to approach their business with a unique set of eyes. 

“Our company takes a patient-focused strategy to help the health care industry quickly and safely bring products to market for those in need. Patient Enrollment Advisors not only finds qualified patients, but we listen to them.”  This humanistic approach makes the clinical trial process a better experience then ever before for everyone involved, which ultimately helps our clients meet their research goals.

David currently works and lives in New York City with his wife and two children.  He is excited to be a partner with SCOPE for the Participant Engagement Awards, which highlights the transformation on how we engage with potential study participants and the awareness of the importance of Clinical Trials.

Hank Scott

Henry (Hank) Scott is a former journalist and media executive whose consulting firm, Media-Maven LLC, is recognized for its work in conflict resolution, organizational culture, and reputation management within media companies. Through Media-Maven, Scott has been deeply involved in moderating workplace disputes, facilitating difficult conversations among staff, and designing codes of conduct for editorial teams. His work often centers on helping organizations understand the psychological dynamics that drive conflict and restoring trust between leadership, employees, and audiences.
Scott’s conflict-resolution practice evolved naturally from his decades in media leadership, where he was frequently tasked with navigating high-stakes interpersonal, editorial, and ethical challenges. He has advised companies—including the publishers of Metro’s free daily newspapers—on reputation management and communication strategies, ensuring that organizational behavior aligns with public expectations and internal values.
Scott has also been involved in executive recruitment and talent assessment for media and nonprofit organizations, applying principles of organizational psychology to help clients identify leaders who will strengthen culture, improve communication, and reduce conflict. This work complements his ombudsman responsibilities by grounding his approach in an understanding of how people work, communicate, and sometimes collide within complex organizations.
Earlier in his career, Scott was a reporter for the Charlotte Observer and Hartford Courant. He later joined The New York Times, where as Vice President for New Media/New Product Development he launched The Times’s first online edition in 1993 and its first foreign-language edition, a Russian publication in Moscow, in 1992. In 1996, he was engaged to turn around the financially struggling Out magazine, where he restructured the organization and created HIV Plus magazine. He went on to launch Metro New York in 2002, establishing a major presence in the U.S. free-daily market.
In 2011, Scott founded WEHOville.com, a hyperlocal news platform serving West Hollywood and the broader LGBTQ+ community in Los Angeles. The site became known for its focus on transparency, accountability, and community dialogue—principles that mirror the core values of ombudsman work.
Scott’s nonprofit involvement includes service on the Board of Governors of the New School (1995–1996), founding the North America Free Daily Newspaper Association in 2007, and joining the CEO Affinity Group in Los Angeles in 2011 to provide insight on governance, leadership, and cross-sector organizational dynamics.
Throughout his career, Scott has consistently worked at the intersection of journalism, organizational psychology, and conflict mediation. His experience resolving disputes, guiding cultural transformation, and helping organizations recruit ethical and collaborative leaders uniquely equips him to serve as an ombudsman.

Scout

Scout is the Executive Director of the National LGBT Cancer Network and the principal investigator of both the CDC-funded LGBTQI+ tobacco-related cancer disparity network and Out: The National Cancer Survey. They spend much of their time providing technical assistance for tobacco and cancer focusing agencies expanding their reach and engagement with LGBTQ+ populations. Scout has a long history in health policy analysis and a particular interest in expanding LGBTQI+ surveillance and research. They have faculty appointments at both Brown University and Boston Universities’ Schools of Public Health. They are a member of FDA’s Tobacco Products Scientific Advisory Committee, a longtime member of the NIH Council of Councils, on the Advisory Panel for NIH’s All of Us initiative, and the former Co-Chair of the NIH Sexual and Gender Minority Research Office Work Group. Their work has won them recognition from the U.S. House of Representatives, two state governments, and many city governments. Scout is an openly nonbinary and trans father of three, a vegetarian, an avid hiker and climber.

Laura Waters

Laura Waters is a specialist physician in HIV & Sexual Health and has been an Executive Director in the Global HIV Medical Affairs team at Gilead since October 2025. 

She qualified from Imperial College School of Medicine in 1998, started specialist training in 2002, undertook a research MD and worked as National Health Service consultant in Central London from 2012-2025, leading care for over 5000 people with HIV. 

Previous roles include Chair of the British HIV Association, National HIV Specialty Advisor to NHS England and Patient Involvement Officer for the Royal College of Physicians. 

Laura has published and presented widely and founded the People First Charter, committed to promoting person-first language, in 2021.

Lorena Kuri

Lorena Kuri, MSMHC, is recognized for her leadership in advancing diversity in clinical trials at BMS. With extensive experience in the pharmaceutical industry, Lorena is dedicated to promoting health equity. Lorena earned a Bachelors in business degree from Tecnológico de Monterrey and a Masters in Strategic Management and Human Capital from Universidad Anáhuac. She also earned a Certificate in Diversity and Inclusion from Cornell University. Lorena is an active member of the Red Shoe Movement, Women of Color in Pharma (WOCIP), and volunteers for her hometown New Providence Diversity Committee.

Demetre Daskalakis

Dr. Demetre C. Daskalakis, MD, MPH, is a nationally recognized physician and public health leader in infectious diseases and emergency response. He received his BA from Columbia, MD from NYU, and MPH from Harvard, followed by advanced training at Harvard’s Beth Israel Deaconess and Partners Healthcare.

Dr. Daskalakis is currently serving as the Chief Medical Officer of Callen-Lorde Community Health Center in New York City, a leader in LGBTQ+ health locally and nationally. Prior to this role, he has held major leadership roles at the New York City Department of Health, overseeing HIV, TB, STD, immunization, and laboratory programs, and managing responses to measles, Legionella, and New York City’s initial COVID-19 outbreak. At the CDC, he directed the Division of HIV Prevention and later led the National Center for Immunization and Respiratory Diseases, where he managed strategies for influenza, COVID-19, RSV, and the transition of the U.S. COVID-19 vaccine program to commercialization. He played a critical role in national responses to respiratory virus threats and managed high-profile outbreaks including measles and avian influenza, demonstrating trauma-informed leadership during challenging events like the August 2025 CDC shooting.

As Deputy Coordinator of the White House National Mpox Response, Dr. Daskalakis’s innovative approaches led to a dramatic reduction in daily cases. Throughout his career, he has championed health equity, LGBTQ+ health, and evidence-based policy, shaping national and global strategies in HIV prevention and vaccination.

Karen Parker

Karen L. Parker, PhD, is a seasoned leader at the National Institutes of Health (NIH), where her work has centered on advancing inclusion of underrepresented populations in clinical and health research. Since joining NIH in 2001 as a Presidential Management Fellow, she has held several key leadership roles, most recently serving as a Senior Scientific Advisor in the NIH Office of the Director and as Director of the Sexual & Gender Minority Research Office (SGMRO). In these positions, she has led efforts to coordinate research, policy, and data standards across the agency.

Dr. Parker earned her PhD from the University of Maryland School of Social Work, an MSW from the University of Michigan, and a BA in English from Indiana University. Her early guidance during SGMA’s formative years played a pivotal role in shaping the organization’s approach to population-level research standards.

Michael Wohlfeiler

Dr. Wohlfeiler received his medical degree from Rush Medical College in Chicago and then completed his residency in Internal Medicine at Jackson Memorial Hospital/University of Miami. He has specialized in HIV Primary Care Medicine since beginning private practice in 1990. In addition to his private practice, in the 1990’s Dr. Wohlfeiler served as the Medical Director of an AIDS hospice program. He became boarded in Hospice and Palliative Medicine and wrote some of the first hospice guidelines specifically for AIDS patients. The National Hospice Organization (NHO) asked Dr. Wohlfeiler to serve on the its Medical Guidelines Task Force where he wrote the NHO’s hospice guidelines for terminally ill patients with AIDS. From 2000 to 2010, Dr. Wohlfeiler served as the Medical Director for Special Immunology Services (SIS) at Mercy Hospital in Miami. SIS was the largest provider of Ryan White medical and case management services for HIV patients in Dade County. He joined AIDS Healthcare Foundation (AHF) in September 2011 when he and his medical partner agreed to have AHF acquire their private practice. In August 2012, he became Regional Medical Director of AHF’s Southern Bureau and in August 2013 he was asked to become AHF’s Chief Medical Officer.


Dr. Wohlfeiler has been extensively involved in HIV clinical research for 30 years and has served as Principal Investigator in over 100 clinical trials. He has authored book chapters and articles about HIV/AIDS and has been a named author on multiple research papers published in peer-reviewed scientific journals. He has spoken extensively on the topic of HIV/AIDS both in the US and abroad. He is considered a Key Opinion Leader in the field of HIV medicine and has been awarded a multitude of awards and accolades over the past three decades. His peers have selected him as one The Best Doctors in America yearly since 1997 and he was selected by the International Association of Internists as one of “The Leading Physicians in the World.” He received a Red Ribbon Hero Award from the Communities Advocating Emergency AIDS Relief (CAEAR) Coalition and was named one of Miami’s “Twelve Good Men” for 2002.


Prior to attending medical school, Dr. Wohlfeiler attended law school at the University of Arizona. While in law school, Dr. Wohlfeiler was awarded a scholarship to work as a staff assistant with a subcommittee of the United States Senate Judiciary Committee in Washington, DC. After receiving his Juris Doctor (JD) and passing the bar exam, he spent 3 unhappy years working as an attorney. He is much happier being a doctor.

Ben Young

Dr. Young is currently an Independent consultant to HIV medicine and street medicine programs while also serving as a Board member of the Wellness Equity Alliance at the Center for Public Health and Human Rights, Johns Hopkins University.

His previous role was at ViiV Healthcare as the Senior Global Medical Director. There he was the Co-Chair of the Clinical Trials Diversity Task Force and his responsibilities included supporting the launch of HIV medicines around the world.

Dr. Young’s experiences as Senior Vice President and Chief Medical Officer of the International Association of Providers of AIDS Care (IAPAC), Adjunct Professor at the Josef Korbel School of International Studies at the University of Denver, expert principal on HIV criminalization and consensus statement on the science of HIV in the context of criminal law, and physician providing care for people living with HIV outline his extensive expertise, education, and support for people living with or affected by HIV.

Dr. Young also co-founded and was Medical Director of Rocky Mountain CARES (now ViventHealth) and has extensive digital communications background: serving as a contributing subject matter expert to the HIV websites TheBody.com and Medscape.com, he authored more than 50,000 online articles ranging from “Ask the Doctor” to scientific conference summaries.

Having authored more than 100 peer-reviewed scientific articles and book chapters relating to HIV and its treatment, Dr. Young shared his HIV expertise through worldwide education programs where he has trained healthcare professionals and community groups in over 50 countries.